Traws Pharma

Traws Pharma

Developer of oral small molecule therapies for respiratory viral diseases and cancer.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
*

$72.6m

Post IPO Equity
Total Funding000k
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads